Alert on the risks associated with the use of ibuprofen: it amplifies the effects of bacteria such as streptococcus and worsens infections

The French drug agency (ANSM) claims to have verified that ibuprofeno and ketoprofeno can aggravate the same infections as those tried to treat these drugs and asked for a survey at the European level. He also issued a series of recommendations for professionals and patients (see list at the bottom of this note).
In 2015, the European Medicines Agency (EMA) had already warned about the cardiovascular risks of this same drug available over the counter in many countries and widely used, especially among children.
A spokesman for the French National Agency for the Safety of Medicines and Health Products (ANSM) told the EFE news agency that "at the request of France" would conduct an badysis collegiate with its European counterparts.
The spokesman reminded that drug licenses are granted throughout Europe, and not only in France, and that it is on this scale that it is appropriate to reevaluate the risk / benefit ratio. of these products.
The ANSM, which launched a pharmacological survey last June through its centers in Tours and Marseille, published Thursday a series of recommendations: first, the privilege of paracetamol on ibuprofen and ketoprofen in case of pain or fever, especially when it comes to infections such as angina, nasopharyngitis, otitis, cough, lungs and even in case of skin lesion or of varicella.